Sveriges mest populära poddar

Cancer Immunotherapy: CAR T as 'Car Race'

3 min•10 mars 2017

GEN Sounds of Science March 9, 2017Brad Loncar, CEO of Loncar Investments, weighs in on recent developments in the scramble to develop CAR T cancer immunotherapies. How significant a setback is Juno Therapeutics’ halting development of JCAR015? How could some second-tier companies yet come out on top in the “car race”?

Hosted on Acast. See acast.com/privacy for more information.

Fler avsnitt av GEN Podcasts

Emerging Markets Collaborate to Succeed in Post-Pandemic World

11 apr. 2023•19 min

Breathing Oxygen Back into the Biological Conversation

6 feb. 2023•19 min

Global Single-Use Network Supports Assurance of Supply

30 jan. 2023•27 min

Resins Address Downstream Purification Concerns

3 jan. 2023•20 min

Materials Sourcing: Precautions and Improvements for Cell and Gene Therapies

1 dec. 2022•21 min

Mechanistic Modeling Improves Drug Discovery Workflows and Speeds Therapeutic Development

1 dec. 2022•23 min

Moving the Drug Pipeline Forward with Mechanistic Modeling

1 dec. 2022•26 min

Reducing Drug Discovery and Development Risk with Mechanistic Modeling

2 maj 2022•40 min

Meet the Editor-in-Chief of GEN Biotechnology: Hana El-Samad, PhD

17 dec. 2021•43 min

Interrogating the Links between Genetics and Psychiatric Disorders with High Throughput Assays

2 dec. 2021•29 min

GEN Podcasts med Genetic Engineering and Biotechnology News finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.